← Back
Data updated: Mar 10, 2026
NASKA
Pharmaceuticals
NASKA is a generic drug manufacturer with 8 FDA-approved products.
1987
Since
8
Drugs
-
Trials
18
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
DIPHENHYDRAMINE HYDROCHLORIDE 2025-11-14
DIPHENHYDRAMINE HYDROCHLORIDE 2025-08-22
DIPHENHYDRAMINE HYDROCHLORIDE 2025-06-24
HYDROCORTISONE 2025-05-02
HYDROCORTISONE 2025-02-03
Labeling
HYDROCORTISONE 2025-02-03
Labeling
HYDROCORTISONE 2024-11-26
Labeling
HYDROCORTISONE 2024-11-26
Labeling
HYDROCORTISONE 2024-11-25
HYDROCORTISONE 2024-09-25
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (0)
Discontinued (8)
Company Info
- First Approval
- 1987-12-21
- Latest
- 1988-07-22
- Applications
- 10